4-(((2-Hydroxy-6-methoxyquinolin-3-yl)methylene)amino)-3-thioxo-6-(3,4,5-trimethoxybenzyl)-3,4-dihydro-1,2,4-triazin-5(2H)-one

ID: ALA4856646

PubChem CID: 164613030

Max Phase: Preclinical

Molecular Formula: C24H23N5O6S

Molecular Weight: 509.54

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2nc(O)c(/C=N/n3c(=S)[nH]nc(Cc4cc(OC)c(OC)c(OC)c4)c3=O)cc2c1

Standard InChI:  InChI=1S/C24H23N5O6S/c1-32-16-5-6-17-14(11-16)10-15(22(30)26-17)12-25-29-23(31)18(27-28-24(29)36)7-13-8-19(33-2)21(35-4)20(9-13)34-3/h5-6,8-12H,7H2,1-4H3,(H,26,30)(H,28,36)/b25-12+

Standard InChI Key:  KOGLCIMBIYSRMX-BRJLIKDPSA-N

Molfile:  

 
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   33.5117  -22.9845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5105  -23.8040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2186  -24.2130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2168  -22.5756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9254  -22.9809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9262  -23.7999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6347  -24.2070    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.3430  -23.7962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.3382  -22.9740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6291  -22.5707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0434  -22.5611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7536  -22.9654    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.4588  -22.5525    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.1669  -22.9595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.8700  -22.5501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.8692  -21.7325    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.1592  -21.3261    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.4499  -21.7372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7396  -21.3330    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   39.1692  -23.7767    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.5786  -22.9571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2854  -22.5468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.9899  -22.9554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6961  -22.5459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6947  -21.7278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.9811  -21.3210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2777  -21.7329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0523  -24.2020    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.9763  -20.5038    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.6816  -20.0911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4009  -21.3166    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.1101  -21.7227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4046  -22.9532    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.4061  -23.7704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8039  -22.5761    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.8037  -21.7589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 14 20  2  0
 15 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  8 28  1  0
 26 29  1  0
 29 30  1  0
 25 31  1  0
 31 32  1  0
 24 33  1  0
 33 34  1  0
  1 35  1  0
 35 36  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4856646

    ---

Associated Targets(Human)

PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PTGS1 Cyclooxygenase-1 (5266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 509.54Molecular Weight (Monoisotopic): 509.1369AlogP: 3.06#Rotatable Bonds: 8
Polar Surface Area: 133.08Molecular Species: NEUTRALHBA: 11HBD: 2
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.36CX Basic pKa: 1.37CX LogP: 3.82CX LogD: 3.55
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.27Np Likeness Score: -0.85

References

1. Ghanim AM, Rezq S, Ibrahim TS, Romero DG, Kothayer H..  (2021)  Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.,  219  [PMID:33892270] [10.1016/j.ejmech.2021.113457]

Source